Coren Lori V, Jain Sumiti, Trivett Matthew T, Ohlen Claes, Ott David E
AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
Biotechniques. 2015 Mar 1;58(3):135-9. doi: 10.2144/000114265. eCollection 2015 Mar.
Here we present an improved strategy for producing T-cell receptor (TCR)-expressing retroviral vectors using a Golden Gate cloning strategy. This method takes advantage of the modular nature of TCR genes by directly amplifying TCR α and β variable regions from RNA or cDNA, then cloning and fusing them with their respective constant region genes resident in a retroviral TCR expression vector. Our one-step approach greatly streamlines the TCR vector production process in comparison to the traditional three-step procedure that typically involves cloning whole TCR genes, producing a TCR expression cassette, and constructing a retroviral construct. To date, we have generated TCR vectors that transferred seven functional human/rhesus macaque TCRs into primary T cells. The approach also holds promise for the assembly of other genes with defined variable regions, such as immunoglobulins.
在此,我们展示了一种利用金门克隆策略生产表达T细胞受体(TCR)的逆转录病毒载体的改进策略。该方法利用TCR基因的模块化特性,通过直接从RNA或cDNA中扩增TCRα和β可变区,然后将它们与逆转录病毒TCR表达载体中各自的恒定区基因进行克隆和融合。与传统的三步程序相比,我们的一步法极大地简化了TCR载体的生产过程,传统方法通常包括克隆完整的TCR基因、生产TCR表达盒以及构建逆转录病毒构建体。迄今为止,我们已经生成了将七种功能性人/恒河猴TCR转移到原代T细胞中的TCR载体。该方法对于组装具有特定可变区的其他基因(如免疫球蛋白)也具有前景。